JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
Scope & Guideline
Transforming clinical research into therapeutic excellence.
Introduction
Aims and Scopes
- Clinical Pharmacotherapy Research:
The journal publishes studies that investigate the efficacy, safety, and pharmacokinetics of various medications used in clinical settings, highlighting how these factors impact patient outcomes. - Pharmacovigilance and Drug Safety:
Research on adverse drug reactions, drug interactions, and the overall safety of medications is a core focus, as the journal aims to improve the understanding of drug-related risks. - Pharmacogenomics and Personalized Medicine:
The publication includes studies that explore the role of genetic variations in drug response, contributing to personalized treatment strategies tailored to individual patient needs. - Pharmaceutical Care Models:
The journal emphasizes innovative pharmaceutical care models that enhance patient engagement and improve medication adherence, particularly in chronic disease management. - Clinical Guidelines and Evidence-Based Practice:
Articles that assess the quality and applicability of clinical guidelines in pharmacotherapy are featured, promoting evidence-based practices among clinicians. - Interdisciplinary Collaboration in Healthcare:
The journal highlights the importance of collaboration between pharmacists and other healthcare professionals to optimize therapeutic outcomes and ensure comprehensive patient care.
Trending and Emerging
- Telepharmacy and Remote Patient Monitoring:
With the rise of telehealth, research on telepharmacy practices and their impact on medication management and patient outcomes has gained momentum, especially during and after the COVID-19 pandemic. - Integrated Care Models for Chronic Disease Management:
There is an increasing emphasis on integrated care models that involve collaboration among healthcare providers to manage chronic diseases effectively, highlighting the pharmacist's role in patient-centered care. - Pharmacogenomics and Precision Medicine:
Research focusing on pharmacogenomics is on the rise, reflecting the shift towards personalized medicine, where treatment is tailored based on individual genetic profiles to optimize therapeutic outcomes. - Antimicrobial Stewardship Programs:
The growing concern over antibiotic resistance has led to an uptick in publications related to antimicrobial stewardship, emphasizing strategies for optimizing antibiotic use in various healthcare settings. - Real-World Evidence and Outcomes Research:
There is a notable trend towards utilizing real-world evidence to assess the effectiveness and safety of medications in diverse populations, moving beyond controlled clinical trial settings.
Declining or Waning
- Traditional Drug Formulations and Delivery Systems:
Research focusing on conventional drug formulations has decreased, as there is a growing interest in novel delivery systems and formulations that enhance bioavailability and therapeutic efficacy. - General Drug Utilization Studies:
While drug utilization studies remain relevant, the focus has shifted towards more specific analyses that include pharmacogenomics and personalized approaches, leading to a decline in broader utilization studies. - Basic Pharmacology and Mechanism of Action Studies:
There has been a noticeable reduction in the publication of basic pharmacological studies without direct clinical implications, as the journal's focus has moved towards translational research that informs clinical practice. - Case Reports on Rare Adverse Events:
Although case reports are valuable, there has been a decrease in publications concerning rare adverse events, possibly due to a preference for studies that provide broader insights into common clinical issues.
Similar Journals
JOURNAL OF PHARMACY PRACTICE AND RESEARCH
Exploring the intersection of research and pharmacy practice.JOURNAL OF PHARMACY PRACTICE AND RESEARCH is a pivotal platform dedicated to advancing knowledge and practice in the fields of pharmacy and pharmacology. Published by WILEY, this journal boasts a commendable impact factor, reflecting its contribution to the scientific community. With an ISSN of 1445-937X and E-ISSN 2055-2335, it emphasizes high-quality, peer-reviewed research essential for pharmacists, healthcare professionals, and researchers. Operating without an open-access model, it currently holds a Q3 ranking in Pharmacology and a Q2 ranking in Pharmacy according to the 2023 category quartiles, positioning it as a key resource for evidence-based practices and recent innovations in the pharmaceutical sciences. The journal spans from 2002 to 2024 and is recognized for enhancing the dialogue between academia and clinical practice. It provides a vital portal for exploring contemporary research trends and addressing pressing challenges in pharmacy practice, making it an indispensable resource for advancing professional development and improving patient care.
ANNALS OF PHARMACOTHERAPY
Advancing the Frontiers of PharmacotherapyANNALS OF PHARMACOTHERAPY, published by SAGE PUBLICATIONS INC, is a leading journal in the realm of pharmacology and therapeutic science, dedicated to advancing research, clinical practice, and education in the field of medicine. With a solid history dating back to its first publication in 1981, this journal offers a platform for high-quality research articles that explore the latest innovations and methodologies in pharmacotherapy. Although it operates under a subscription-based model, the journal maintains a robust academic reputation, reflected in its Scopus ranking in the 68th percentile within the category of Medicine - Pharmacology (Rank #85/272). The impact factor is continually evolving, as is the scope, which encompasses a diverse range of topics from clinical trials to the therapeutic applications of newly-developed drugs. Researchers, professionals, and students alike will find valuable insights and cutting-edge research in the ANNALS OF PHARMACOTHERAPY, making it an essential resource for anyone engaged in the field of pharmacology.
CANADIAN JOURNAL OF HOSPITAL PHARMACY
Elevating Standards in Hospital Pharmacy ExcellenceCanadian Journal of Hospital Pharmacy, published by the Canadian Society of Hospital Pharmacists, stands as a pivotal resource within the field of pharmacy and medical pharmacology since its inception in 1973. With its ISSN 0008-4123, this peer-reviewed journal aims to advance the knowledge and practice of hospital pharmacy through the dissemination of high-quality research, reviews, and case studies. Although currently not an open-access journal, it boasts a respectable influence in the academic community, reflected in its Q3 quartile rankings in both pharmacology and pharmacy as of 2023. Located in Ottawa, Canada, the journal encourages contributions that emphasize evidence-based practices and innovative solutions to enhance patient care. By fostering a dialogue among pharmacists, researchers, and healthcare professionals, the Canadian Journal of Hospital Pharmacy continues to be an essential platform for addressing contemporary issues and advancements in the hospital pharmacy landscape.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
Driving change in health policy with scholarly contributions.American Journal of Health-System Pharmacy, published by Oxford University Press Inc., stands as a vital resource in the domains of pharmacy and health policy. With an ISSN of 1079-2082 and E-ISSN 1535-2900, this esteemed journal provides a platform for disseminating high-quality research and insights that influence the practice of pharmacy and health management. The journal boasts a Q1 ranking in Pharmacy and ranks within the top quartiles in Health Policy and Medicine, reflecting its substantial impact on the field. With a comprehensive focus extending from 1995 to 2024, it caters to a diverse audience, including health professionals, researchers, and students interested in the ever-evolving dynamics of health-system pharmacy. Although it does not offer Open Access, the journal ensures that subscribers gain access to cutting-edge research essential for advancing health implications in pharmacy practice. By prioritizing innovative studies and reviews, the American Journal of Health-System Pharmacy plays a crucial role in shaping effective pharmaceutical care strategies and policies.
JOURNAL OF PHARMACY PRACTICE
Elevating pharmacy practice with cutting-edge insights.JOURNAL OF PHARMACY PRACTICE, published by SAGE PUBLICATIONS INC, is a vital resource for researchers, pharmacy practitioners, and students dedicated to advancing the pharmacological and pharmaceutical sciences. Established in 1988, the journal serves as a platform for original research, reviews, and critical analyses in the fields of pharmacy and pharmacology. With an impressive impact factor and a strong presence in the Q2 category in Pharmacy and Q3 in Pharmacology (medical) as of 2023, it reflects the journal's commitment to delivering high-quality scholarly content that addresses pressing issues in pharmacy practice and medication management. The journal is indexed in Scopus, ranking #154 out of 272 in the field of Medicine and Pharmacology, positioning it within the 43rd percentile. Although it currently does not offer open access options, it remains an essential publication for those seeking to stay updated on innovations and best practices in the pharmacy sector, making it an indispensable tool for academic and professional growth.
DRUGS & THERAPY PERSPECTIVES
Transforming Insights into Therapeutic ExcellenceDRUGS & THERAPY PERSPECTIVES is an esteemed journal published by SpringerNature, dedicated to advancing knowledge in the field of pharmacology and therapeutic studies. With an ISSN of 1172-0360 and an E-ISSN of 1179-1977, this journal has been providing valuable insights since its inception in 1993 and continues to publish until 2024. Ranked in the Q3 category for Pharmacology (medical) and positioned within the 25th percentile according to Scopus rankings, it serves as a vital resource for researchers, practitioners, and students alike. Although it is not an open-access journal, it offers a comprehensive platform for innovative research, clinical practices, and evolving therapeutic strategies, reflecting the critical developments in drug therapy landscape. With its strategic emphasis on bridging academic studies and clinical applications, DRUGS & THERAPY PERSPECTIVES remains essential for those committed to enhancing drug efficacy and patient outcomes in the ever-evolving medical field.
Ars Pharmaceutica
Pioneering research that shapes the future of pharmacy.Ars Pharmaceutica is a distinguished open-access journal published by UNIV GRANADA, EDITORIAL, that has been at the forefront of pharmaceutical sciences since its establishment. With ISSN 0004-2927 and E-ISSN 2340-9894, this journal aims to disseminate high-quality research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of the field. With a historical scope that spans from 1980 to 2017, it has played a pivotal role in shaping the discourse surrounding pharmaceutical science and its intersection with the arts and humanities. Although currently ranked within the 13th percentile in Scopus for Pharmaceutical Science and the 11th percentile for History and Philosophy of Science, Ars Pharmaceutica continues to uphold its commitment to academic excellence and innovation. By providing a platform for open-access research, it encourages collaboration and knowledge sharing among researchers, professionals, and students, thus enhancing the broader understanding of pharmaceutical developments and their societal implications.
PHARMACOTHERAPY
Inspiring Breakthroughs in Therapeutic StrategiesPHARMACOTHERAPY, an esteemed journal published by WILEY, stands as a pivotal resource within the field of medical pharmacology. With its ISSN 0277-0008 and E-ISSN 1875-9114, this journal has been at the forefront of pharmacological research since its inception in 1981. Renowned for its rigorous peer-review process and impactful contributions, it currently holds a prestigious Q1 quartile ranking in the pharmacology category, underscoring its significance as a leading publication in the field. It ranks #40 out of 272 journals in Scopus, placing it in the top 15% percentile of its category. While not an open-access publication, PHARMACOTHERAPY remains committed to advancing knowledge and understanding in pharmacological sciences, making it an indispensable resource for researchers, healthcare professionals, and students dedicated to improving therapeutic outcomes and drug utilization. Based in the United States, at 111 River St, Hoboken, NJ, the journal is poised to continue its impact through to 2024 and beyond, welcoming contributions that further the discourse in pharmacotherapy.
Journal of Pharmaceutical Health Care and Sciences
Enhancing global health through open access pharmaceutical knowledge.The Journal of Pharmaceutical Health Care and Sciences is a premier open access journal published by BMC that aims to advance the field of pharmaceutical sciences by providing high-quality research and comprehensive reviews across various domains including pharmacology, nursing, and healthcare. With an impact factor reflecting its relevance and rigor, the journal has established itself as a significant platform for disseminating knowledge since its inception in 2015. The journal is indexed in Scopus, currently holding a position in the Q3 quartile for medical pharmacology and Q2 quartile for nursing pharmacology, indicating its growing influence and reach in the scientific community. Based in the United Kingdom with a commitment to open access, the Journal of Pharmaceutical Health Care and Sciences ensures that all researchers, professionals, and students have free access to vital research that fosters innovation and improves healthcare outcomes worldwide. With a focus on collaborative and multidisciplinary approaches, the journal invites contributions that align with its objectives of enhancing health care delivery and pharmaceutical practices.
Journal of Young Pharmacists
Bridging Theory and Practice in PharmacologyJournal of Young Pharmacists is a distinguished peer-reviewed journal published by INPHARM ASSOCIATION in collaboration with PHCOG NET. With an ISSN of 0975-1483 and an E-ISSN of 0975-1505, this journal serves as a vital platform for disseminating pioneering research in the field of pharmacology and toxicology. Although coverage in Scopus was discontinued in 2018, the journal continues to be important in educating future pharmacists and advancing the discipline, evident from its ranking in the 29th percentile among general pharmacology journals. The Journal of Young Pharmacists seeks to bridge the gap between theoretical knowledge and practical application, encouraging young researchers, professionals, and students to contribute their insights and findings. The journal emphasizes innovative approaches and contemporary issues relevant to the pharmaceutical sciences, making it an invaluable resource for anyone involved in this dynamic field.